Test your knowledge on chemotherapy for mTNBC

Combination chemotherapy is recommended for patients at risk for or in visceral crisis. True or false?
True
False
Which of the following regimens is recommended as a second-line therapy for patients with no germline BRCA mutation and no PD-L1 expression?
Pembrolizumab
Olaparib
Sacituzumab govitecan
Carboplatin
Which of the following regimens are recommended as a second-line therapy for patients with a known germline BRCA mutation and no PD-L1 expression?
Single-agent chemotherapy
Olaparib
Pembrolizumab
Single-agent chemotherapy and olaparib
Pembrolizumab combined with chemotherapy is approved for which patients?
PD-L1 with a CPS ≥5
PD-L1 with a CPS ≥10
PD-L1 negative
PD-L1 negative and no germline BRCA
0
{"name":"Test your knowledge on chemotherapy for mTNBC", "url":"https://www.quiz-maker.com/QB8YUJQ9A","txt":"Combination chemotherapy is recommended for patients at risk for or in visceral crisis. True or false?, Which of the following regimens is recommended as a second-line therapy for patients with no germline BRCA mutation and no PD-L1 expression?, Which of the following regimens are recommended as a second-line therapy for patients with a known germline BRCA mutation and no PD-L1 expression?","img":"https://www.quiz-maker.com/3012/images/ogquiz.png"}